- Home
- AHMA vs BIOA Comparison
AHMA vs BIOA Comparison
Compare AHMA & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AHMA | BIOA |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1M | 175.7M |
| IPO Year | 2025 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AHMA | BIOA |
|---|---|---|
| Price | $7.09 | $12.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.33 |
| AVG Volume (30 Days) | ★ 2.8M | 294.4K |
| Earning Date | 12-08-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $18,543,447.00 | $5,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $213.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.00 | $2.88 |
| 52 Week High | $18.20 | $12.30 |
Technical Indicators
Market Signals| Indicator | AHMA | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 80.56 |
| Support Level | N/A | $8.46 |
| Resistance Level | N/A | $9.62 |
| Average True Range (ATR) | 0.00 | 0.65 |
| MACD | 0.00 | 0.28 |
| Stochastic Oscillator | 0.00 | 94.37 |
Price Performance
Historical ComparisonAbout AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.